相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinoma
Kousuke Kubota et al.
HEPATOLOGY RESEARCH (2018)
Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial
Masafumi Ikeda et al.
JOURNAL OF GASTROENTEROLOGY (2018)
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma
G. K. Abou-Alfa et al.
ANNALS OF ONCOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Lorenza Rimassa et al.
LANCET ONCOLOGY (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
Masatoshi Kudo et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization
Boris Gorodetski et al.
EUROPEAN RADIOLOGY (2017)
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
Arnaud Monier et al.
EUROPEAN RADIOLOGY (2017)
Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules
Yusuke Kawamura et al.
HEPATOLOGY RESEARCH (2017)
Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinoma
Kenji Ikeda et al.
HEPATOLOGY RESEARCH (2017)
Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization
Manabu Morimoto et al.
ABDOMINAL RADIOLOGY (2017)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Switch to miriplatin for multinodular hepatocellular carcinoma unresponsive to transarterial chemoembolization with epirubicin: a prospective study
Yoshihiro Goda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
Tim Meyer et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
Takamasa Ohki et al.
ADVANCES IN THERAPY (2017)
Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma
Mitsunari Maruyama et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2016)
Diameter of main tumor feeding artery of a hepatocellular carcinoma: Measurement at the entry site into the nodule
Toshiyuki Irie et al.
HEPATOLOGY RESEARCH (2016)
Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short-term results
Masahiro Ogawa et al.
HEPATOLOGY RESEARCH (2016)
Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super-selective TACE
Toshiyuki Irie et al.
HEPATOLOGY RESEARCH (2016)
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
Antonio Facciorusso et al.
DIGESTIVE AND LIVER DISEASE (2016)
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
Karen T. Brown et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Subclassification of Barcelona Clinic Liver Cancer B and C hepatocellular carcinoma: A cohort study of the multicenter registry database
Sangheun Lee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma
Antonio Facciorusso et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma
Atsushi Hiraoka et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
Riccardo Lencioni et al.
JOURNAL OF HEPATOLOGY (2016)
Proposed New Sub-Grouping for intermediate-Stage Hepatotceliular Carcinoma Using Albumin-Bilirubin Grade
Atsushi Hiraoka et al.
ONCOLOGY (2016)
Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion
Feng Duan et al.
RADIOLOGY (2016)
Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
Roman Kloeckner et al.
BMC CANCER (2015)
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice
Amit G. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2015)
SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
Calin Cainap et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma
Fahrettin Kucukay et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Transarterial Chemoembolization Using Gelatin Sponges or Microspheres Plus Lipiodol-Doxorubicin versus Doxorubicin-Loaded Beads for the Treatment of Hepatocellular Carcinoma
Yi-Sheng Liu et al.
KOREAN JOURNAL OF RADIOLOGY (2015)
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Doxorubicin-loaded Drug-eluting beads Versus Conventional Transarterial Chemoembolization for Nonresectable Hepatocellular Carcinoma
Mohammad Arabi et al.
SAUDI JOURNAL OF GASTROENTEROLOGY (2015)
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
Tadaaki Arizumi et al.
LIVER CANCER (2015)
Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma
Michael B. Pitton et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma
Hirotaka Arai et al.
HEPATOLOGY RESEARCH (2015)
Efficacy and safety of cisplatin versus miriplatin in transcatheter arterial chemoembolization and transarterial infusion chemotherapy for hepatocellular carcinoma: A randomized controlled trial
Kentarou Otsuji et al.
HEPATOLOGY RESEARCH (2015)
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study
Kiwamu Okita et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
Brivanib as Adjuvant Therapy to Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma: A Randomized Phase III Trial
Masatoshi Kudo et al.
HEPATOLOGY (2014)
Transcatheter arterial chemoembolization for hepatocellular carcinoma: Comparison of the therapeutic efficacies between miriplatin and epirubicin
Takahiro Handa et al.
HEPATOLOGY RESEARCH (2014)
Chemoembolization-induced arterial damage: Evaluation of three different chemotherapeutic protocols using epirubicin and miriplatin
Jin Iwazawa et al.
HEPATOLOGY RESEARCH (2014)
Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib The EVOLVE-1 Randomized Clinical Trial
Andrew X. Zhu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Subgrouping of intermediate-stage (BCLC stage B) hepatocellular carcinoma based on tumor number and size and Child-Pugh grade correlated with prognosis after transarterial chemoembolization
Koichiro Yamakado et al.
JAPANESE JOURNAL OF RADIOLOGY (2014)
Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis
Yeonjung Ha et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
Sadahisa Ogasawara et al.
ONCOLOGY (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure
Toshiyuki Irie et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Comparison of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinoma
Takeshi Aramaki et al.
HEPATOLOGY RESEARCH (2013)
Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinoma
Yuya Seko et al.
HEPATOLOGY RESEARCH (2013)
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Philip J. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
Josep M. Llovet et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sunitinib Versus Sorafenib in Advanced Hepatocellular Cancer: Results of a Randomized Phase III Trial
Ann-Lii Cheng et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Prospective Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: An Asian Cooperative Study between Japan and Korea
Masafumi Ikeda et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Single-center Comparison of Three Chemoembolization Regimens for Hepatocellular Carcinoma
Nicholas J. Petruzzi et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2013)
Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation
Daniele Nicolini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Transarterial Chemoembolization With Cisplatin as Second-Line Treatment for Hepatocellular Carcinoma Unresponsive to Chemoembolization With Epirubicin-Lipiodol Emulsion
Noboru Maeda et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Switching the Loaded Agent from Epirubicin to Cisplatin: Salvage Transcatheter Arterial Chemoembolization with Drug-eluting Microspheres for Unresectable Hepatocellular Carcinoma
Akihiko Seki et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2012)
Short-term therapeutic effects of transcatheter arterial chemoembolization using miriplatin-lipiodol suspension for hepatocellular carcinoma
Sota Oguro et al.
JAPANESE JOURNAL OF RADIOLOGY (2012)
Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma
Shiro Miyayama et al.
JAPANESE JOURNAL OF RADIOLOGY (2012)
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma
Myeong Jun Song et al.
JOURNAL OF HEPATOLOGY (2012)
A retrospective comparative study of epirubicin-lipiodol emulsion and cisplatin-lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma
Hiraku Yodono et al.
ANTI-CANCER DRUGS (2011)
Transcatheter Arterial Chemoembolization with Epirubicin-Loaded Superabsorbent Polymer Microspheres for 135 Hepatocellular Carcinoma Patients: Single-Center Experience
Akihiko Seki et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
Masatoshi Kudo et al.
EUROPEAN JOURNAL OF CANCER (2011)
Comparative study of cisplatin and epirubicin in transcatheter arterial chemoembolization for hepatocellular carcinoma
Kenya Yamanaka et al.
HEPATOLOGY RESEARCH (2011)
Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
Rodolfo Sacco et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2011)
Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
Philipp Wiggermann et al.
MEDICAL SCIENCE MONITOR (2011)
A Randomized Phase II Study of Drug-Eluting Beads versus Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma
Hannah van Malenstein et al.
ONKOLOGIE (2011)
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
Katerina Malagari et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma
Shinya Sahara et al.
JAPANESE JOURNAL OF RADIOLOGY (2010)
Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis
Mario Scartozzi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Transarterial Chemoembolization with Epirubicin-eluting Beads versus Transarterial Embolization before Liver Transplantation for Hepatocellular Carcinoma
Antonio Nicolini et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Transcatheter arterial chemoembolization with a fine-powder formulation of cisplatin for hepatocellular carcinoma
Kazuhiro Kasai et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Evaluation of Tumor Response After Locoregional Therapies in Hepatocellular Carcinoma Are Response Evaluation Criteria in Solid Tumors Reliable?
Alejandro Forner et al.
CANCER (2009)
Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats
Mitsuharu Hanada et al.
CANCER SCIENCE (2009)
Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
Yusuke Kawamura et al.
HEPATOLOGY RESEARCH (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Transarterial Chemoembolization for Hepatocellular Carcinoma with Drug-Eluting Microspheres: Preliminary Results from an Italian Multicentre Study
Maurizio Grosso et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Chemoembolization of hepatocellular carcinoma with drug eluting beads
Paolo Del Poggio et al.
JOURNAL OF HEPATOLOGY (2007)
Chemoembolization of hepatocellular carcinoma with drug eluting beads:: Efficacy and doxorubicin pharmacokinetics
Maria Varela et al.
JOURNAL OF HEPATOLOGY (2007)
Ultraselective transcatheter arterial chemoembolization with a 2-F tip microcatheter for small hepatocellular carcinomas: Relationship between local tumor recurrence and visualization of the portal vein with iodized oil
Shiro Miyayama et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan
Masatoshi Makuuchi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol
S Fujiyama et al.
BRITISH JOURNAL OF CANCER (2003)
Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: Comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion
K Kamada et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2001)
Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma
Y Ono et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2000)
分享论文
